Neoadjuvant immunotherapy for colorectal cancer: Right regimens, right patients, right directions?
Neoadjuvant chemoradiotherapy (NACRT) or chemotherapy (NACT) followed by radical resection and then adjuvant therapy is considered the optimal treatment model for locally advanced colorectal cancer (LACRC). A recent total neoadjuvant therapy (TNT) strategy further improved the tumour regression rate...
Main Authors: | Jiahao Zhu, Jie Lian, Benjie Xu, Xiangyi Pang, Shengjun Ji, Yutian Zhao, Haibo Lu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-03-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2023.1120684/full |
Similar Items
-
Immunotherapy regimens for metastatic colorectal carcinomas
by: Babar Bashir, et al.
Published: (2018-02-01) -
Pathological complete response after neoadjuvant immunotherapy combined with chemotherapy in pediatric rectal carcinoma: A case report
by: Xiaomeng Cao, et al.
Published: (2022-12-01) -
Case report: Efficacy of immunotherapy as conversion therapy in dMMR/MSI-H colorectal cancer: a case series and review of the literature
by: María San-Román-Gil, et al.
Published: (2024-02-01) -
Immunotherapy, Inflammation and Colorectal Cancer
by: Charles Robert Lichtenstern, et al.
Published: (2020-03-01) -
Immunotherapy with Immune Checkpoint Inhibitors for Advanced Colorectal Cancer: A Promising Individualized Treatment Strategy
by: Ying Yang, et al.
Published: (2023-04-01)